Crystal Violet Selectively Detects Aβ Oligomers but Not Fibrils In Vitro and in Alzheimer’s Disease Brain Tissue
Biomolecules · 23.05.2024 · 14 (6) · 615
DOI: 10.3390/biom14060615 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 23.05.2024. Verfasst von Kanchana Karunarathne und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, University of South Florida, Tampa, FL 33620, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Brain, Gentian Violet. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIH HHS, NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Deposition of extracellular Amyloid Beta (Aβ) and intracellular tau fibrils in post-mortem brains remains the only way to conclusively confirm cases of Alzheimer’s Disease (AD). Substantial evidence, though, implicates small globular oligomers instead of fibrils as relevant biomarkers of, and critical contributors to, the clinical symptoms of AD. Efforts to verify and utilize amyloid oligomers as AD biomarkers in vivo have been limited by the near-exclusive dependence on conformation-selective antibodies for oligomer detection. While antibodies have yielded critical evidence for the role of both Aβ and tau oligomers in AD, they are not suitable for imaging amyloid oligomers in vivo. Therefore, it would be desirable to identify a set of oligomer-selective small molecules for subsequent development into Positron Emission Tomography (PET) probes. Using a kinetics-based screening assay, we confirm that the triarylmethane dye Crystal Violet (CV) is oligomer-selective for Aβ42 oligomers (AβOs) grown under near-physiological solution conditions in vitro. In postmortem brains of an AD mouse model and human AD patients, we demonstrate that A11 antibody-positive oligomers but not Thioflavin S (ThioS)-positive fibrils colocalize with CV staining, confirming in vitro results. Therefore, our kinetic screen represents a robust approach for identifying new classes of small molecules as candidates for oligomer-selective dyes (OSDs). Such OSDs, in turn, provide promising starting points for the development of PET probes for pre-mortem imaging of oligomer deposits in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physics, University of South Florida, Tampa, FL 33620, USA.
- Department of Molecular Medicine, USF Health, Morsani College of Medicine, Tampa, FL 33620, USA.
- Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
ORCID-Profile: Teresa R Kee, Hanna Jeon, Yasith I Gamage, Jung-A A Woo
Förderung
- BLRD VA
- NIH HHS
- NIA NIH HHS
- NINDS NIH HHS
- United States Department of Veterans Affairs
- National Institutes of Health
- Veterans Affairs
- Howard T. Karsner Professorship in Pathology, CWRU
Zitieren
APA
Karunarathne, K., Kee, T. R., Jeon, H., Cazzaro, S., Gamage, Y. I., Pan, J., Woo, J. A., Kang, D. E., & Muschol, M. (2024). Crystal Violet Selectively Detects Aβ Oligomers but Not Fibrils In Vitro and in Alzheimer’s Disease Brain Tissue. Biomolecules, 14(6), 615. https://doi.org/10.3390/biom14060615
Vancouver
Karunarathne K, Kee TR, Jeon H, Cazzaro S, Gamage YI, Pan J, et al. Crystal Violet Selectively Detects Aβ Oligomers but Not Fibrils In Vitro and in Alzheimer’s Disease Brain Tissue. Biomolecules. 2024;14(6):615. doi:10.3390/biom14060615
BibTeX
@article{Karunarathne2024,
author = {Karunarathne, Kanchana and Kee, Teresa R and Jeon, Hanna and Cazzaro, Sara and Gamage, Yasith I and Pan, Jianjun and Woo, Jung-A A and Kang, David E and Muschol, Martin},
title = {Crystal Violet Selectively Detects Aβ Oligomers but Not Fibrils In Vitro and in Alzheimer’s Disease Brain Tissue},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {6},
pages = {615},
doi = {10.3390/biom14060615}
}
EUVIMED